Regillo C D, Blade K A, Custis P H, O'Connell S R
Ophthalmology Department, Naval Medical Center, San Diego, California, USA.
Ophthalmology. 1998 Oct;105(10):1821-6. doi: 10.1016/S0161-6420(98)91022-3.
To evaluate the clinical utility of routinely using indocyanine green angiography (ICGA) with fluorescein angiography (FA) in detecting persistent or recurrent choroidal neovascularization (CNV).
Prospective, consecutive case series.
Twenty-four eyes of 21 patients with exudative age-related macular degeneration (AMD) that had conventional laser treatment for CNV were examined.
Fluorescein angiography and ICGA were performed together on all eligible eyes at the first post-treatment visit and all subsequent follow-up visits in which persistent or recurrent CNV was suspected clinically.
Choroidal neovascularization detection and delineation by each angiographic technique were measured.
Of the 54 FA-ICGA study pairs performed over a 20-month investigation period, FA showed well-defined, ill-defined, and no CNV in 10 (19%), 19 (35%), and 25 (46%) eyes, respectively. Indocyanine green angiography had a high concordance rate at 70% and 88% when persistent or recurrent CNV was well-defined and absent, respectively, on FA and rarely added additional, clinically useful information in these settings, particularly in the former presentation. Of the 29 eyes that showed some evidence of CNV by FA, the neovascular complex was ill-defined in 19 (66%) eyes. When CNV was ill-defined by FA, the corresponding ICGA showed well-defined CNV in 9 (47%) of 19 eyes, in 5 of which the CNV was nonsubfoveal in location.
Persistent or recurrent CNV in AMD was frequently ill-defined by FA. Indocyanine green angiography was a valuable adjunct to FA by better delineating CNV in this specific setting. However, ICGA was not useful when the post-treatment FA showed well-defined CNV. Furthermore, ICGA was not helpful when the first post-treatment FA was negative and there were no ophthalmoscopic signs of exudation.
评估常规使用吲哚菁绿血管造影(ICGA)联合荧光素血管造影(FA)检测持续性或复发性脉络膜新生血管(CNV)的临床效用。
前瞻性连续病例系列研究。
21例患有渗出性年龄相关性黄斑变性(AMD)且接受过CNV常规激光治疗的患者的24只眼接受了检查。
在首次治疗后随访以及所有后续随访(临床怀疑有持续性或复发性CNV时)对所有符合条件的眼睛同时进行荧光素血管造影和ICGA检查。
测量每种血管造影技术对脉络膜新生血管的检测和描绘情况。
在为期20个月的研究期间进行的54对FA-ICGA研究中,FA显示明确界定的CNV、界定不清的CNV和无CNV的眼数分别为10只(19%)、19只(35%)和25只(46%)。当FA显示持续性或复发性CNV明确界定和不存在时,吲哚菁绿血管造影的符合率分别为70%和88%,并且在这些情况下很少能提供额外的、具有临床价值的信息,尤其是在前一种表现中。在29只通过FA显示有CNV迹象的眼中,19只(66%)眼的新生血管复合体界定不清。当FA显示CNV界定时,相应的ICGA在19只眼中的9只(47%)显示明确界定的CNV,其中5只眼的CNV位于黄斑中心凹以外。
AMD中持续性或复发性CNV常难以通过FA明确界定。吲哚菁绿血管造影在这种特定情况下通过更好地描绘CNV是FA的一项有价值的辅助手段。然而,当治疗后的FA显示明确界定的CNV时ICGA并无用处。此外,当首次治疗后的FA为阴性且无眼底渗出体征时,ICGA也无帮助。